Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia

被引：1
|
作者：
Lucchetti, Jessica [1 ]
Formica, Vincenzo [1 ]
Giuliano, Greta [1 ]
Coletta, Deborah [1 ]
Gargano, Letizia [1 ]
Morosetti, Daniele [2 ]
Sileri, Pierpaolo [3 ]
Palmieri, Giampiero [4 ]
Roselli, Mario [1 ]
机构：
[1] Tor Vergata Univ, Med Oncol Unit, Viale Oxford 81, I-00133 Rome, Italy
[2] Tor Vergata Univ, Diagnost Imaging Dept, Rome, Italy
[3] Tor Vergata Univ, Surg Dept, Rome, Italy
[4] Tor Vergata Univ, Anat Pathol Dept, Rome, Italy
来源：
ANTICANCER RESEARCH | 2018年 / 38卷 / 11期
关键词：
Breast; metastasis; gastric cancer; regional hyperthermia; case report;
D O I：
10.21873/anticanres.13022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Breast metastases from extra mammary tumors are extremely rare. Case Report: Here we report the case of a 50-year-old female with histologically-confirmed gastric cancer metastasis to the breast who was adequately treated with loco-regional hyperthermia plus standard second-line chemotherapy (paclitaxel plus ramucirumab). The best response achieved was a relatively long disease stabilization. Conclusion: Chemotherapy plus regional hyperthermia has been shown to have a synergistic antitumor effect and possible favorable immunomodulatory effects. Such an approach merits further investigation especially for the treatment of rare superficial metastatic sites.
引用
收藏
页码：6561 / 6564
页数：4
相关论文
共 50 条
  • [1] Ramucirumab plus paclitaxel for gastric cancer in China
    Yoon, Harry H.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 975 - 976
  • [2] Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis A case report
    Yang, Min Joo
    Choi, Young Jin
    Kim, Hyo Jeong
    Kim, Do Young
    Seol, Young Mi
    [J]. MEDICINE, 2021, 100 (07) : E24795
  • [3] Fulminant Fournier's gangrene in a patient with gastric cancer treated with ramucirumab and paclitaxel
    Rakusic, Zoran
    Krpan, Ana Misir
    Sjekavica, Ivica
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [4] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Ishikawa, Masashi
    Iwasa, Satoru
    Nagashima, Kengo
    Aoki, Masahiko
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Saruta, Masayuki
    Boku, Narikazu
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 533 - 540
  • [5] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Masashi Ishikawa
    Satoru Iwasa
    Kengo Nagashima
    Masahiko Aoki
    Hiroshi Imazeki
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Masayuki Saruta
    Narikazu Boku
    [J]. Investigational New Drugs, 2020, 38 : 533 - 540
  • [6] Gastric metastasis from breast cancer in male patient - Case report and literature review
    Cardoso, Tiago Magalhaes
    Dias, Douglas Dallas Muniz
    Cohen, Joanna Cyrene Duarte Chagas
    Rodriguez, Juan Eduardo Rios
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2021, 87
  • [7] Comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as 2nd-line treatment for gastric cancer
    Tsuji, Kunihiro
    Miyajima, Saori
    Kito, Yosuke
    Doyama, Hisashi
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S330 - S330
  • [8] Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer
    Hayase, Suguru
    Yamada, Leo
    Ujiie, Daisuke
    Nirei, Azuma
    Tada, Takeshi
    Hanayama, Hiroyuki
    Monma, Tomoyuki
    Saze, Zenichiro
    Ohki, Shinji
    Kono, Koji
    [J]. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2019, 65 (01) : 6 - 12
  • [9] Examination of utility in patients of unresectable or recurrent gastric cancer treated with paclitaxel or nab-paclitaxel or paclitaxel plus ramucirumab in our hospital
    Kii, T.
    Gotoh, M.
    Terazawa, T.
    Yamaguchi, T.
    Asaishi, K.
    Aoki, M.
    Ikegami, T.
    Higuchi, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 61 - 61
  • [10] Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial
    Sato, Yasuyoshi
    Yamashita, Hiroharu
    Yagi, Koichi
    Nomura, Sachiyo
    Seto, Yasuyuki
    [J]. ANTICANCER RESEARCH, 2024, 44 (07) : 3125 - 3131
12345